7Baggers

Apollo Medical Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20181231 20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 -3.3146.9197.13147.34197.56247.78297.99348.21Milllion

Apollo Medical Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2014-01-31 2013-10-31 2013-07-31 2013-04-30 2013-01-31 2012-10-31 2012-07-31 2012-04-30 2012-01-31 2011-10-31 2011-07-31 2011-04-30 2011-01-31 2010-10-31 2010-07-31 2010-04-30 2010-01-31 2009-10-31 2009-07-31 2009-04-30 2009-01-31 2008-10-31 2008-07-31 2008-03-31 2007-06-30 
  revenue348,173,000 348,209,000 337,244,000 294,208,000 317,001,000 269,697,000 263,258,000 195,100,000 227,117,000 175,638,000 176,058,000 176,783,000 180,123,000 165,169,000 165,105,000 178,751,136 156,060,000 130,050,000 95,758,000 105,456,069 167,280,410 123,004,546 124,166,727 259,500,000 40,483,346 41,575,480 14,758,496 15,674,876 14,622,656 12,371,673 11,815,299 10,659,708 11,369,607 10,204,125 9,587,488 7,642,474 11,665,294 4,094,486 2,839,462 2,839,462 2,605,231 2,593,046 2,446,566 2,529,683 1,965,153 1,649,451 1,631,844 1,545,440 1,431,965 1,093,708 1,039,693 1,034,926 1,019,078 1,039,695 802,885 742,352 616,975 580,942 501,183 557,751 479,808 9,795 10,000 26,500 
  cost of revenue275,375,000 292,876,000 289,397,000 253,119,000 240,768,000 230,070,000 220,730,000 171,839,000 147,473,000 136,214,000 140,616,000 137,105,000 121,823,000 136,079,000 144,204,000 151,879,511 131,130,000 101,363,000 83,432,000 79,410,425 96,828,245 99,464,892 84,670,608 180,400,000 39,096,618 40,239,642 13,715,485 12,715,864 12,171,183 10,133,005 9,705,188 8,463,541 8,264,189 7,567,868 6,555,592 6,090,345 6,161,645 3,259,839 2,708,712 2,708,712 2,140,615 2,366,393 1,860,493 1,982,875 1,798,957 1,205,673 1,328,659 1,139,379 1,097,132 939,337 947,489 907,198 868,119 864,719 674,686 551,514 455,183 387,692 419,554 640,802 488,605 15,620 18,875 
  gross profit72,798,000 55,333,000 47,847,000 41,089,000 76,233,000 39,627,000 42,528,000 23,261,000 79,644,000 39,424,000 35,442,000 39,678,000 58,300,000 29,090,000 20,901,000 26,871,625 24,930,000 28,687,000 12,326,000 26,045,644 70,452,165 23,539,654 39,496,119 79,100,000 1,386,728 1,335,838 1,043,011 2,959,012 2,451,473 2,238,668 2,110,111 2,196,167 3,105,418 2,636,257 3,031,896 1,552,129 5,503,649 834,647 130,750 130,750 464,616 226,653 586,073 546,808 166,196 443,778 303,185 406,061 334,833 154,371 92,204 127,728 150,959 174,976 128,199 190,838 161,792 193,250 81,629 -83,051 -8,797 -5,825 10,000 7,625 
  operating expenses                                                                
  research and development
  sales, general and administrative                                                                
  total operating expenses33,715,000 28,304,000 25,474,000 28,509,000 26,142,000 24,245,000 16,317,000 21,013,000 26,484,000 18,436,000 13,661,000 13,802,000 20,944,000 16,184,000 16,536,000 15,938,715 12,870,000 13,959,000 15,633,000 20,243,176 13,875,061 16,389,907 16,794,410 30,600,000 5,501,679 5,044,451 5,967,231 4,634,866 4,625,884 4,001,133 5,839,163 3,655,639 3,518,325 4,300,954 2,866,578 3,083,658 3,645,188 2,021,231 1,154,783 1,154,783 1,278,103 1,587,040 1,298,045 1,071,891 1,603,421 506,804 356,338 675,616 208,631 237,710 279,648 141,797 154,343 193,509 88,198 265,501 149,179 132,443 182,900 29,727 288,850 330,980 83,134 66,993 
  operating income39,083,000 27,029,000 22,373,000 12,580,000 50,091,000 15,382,000 26,211,000 2,248,000 53,160,000 20,988,000 21,781,000 25,876,000 37,356,000 12,906,000 4,365,000 10,932,910 10,066,000 14,728,000 -3,307,000 2,003,602 56,577,104 7,149,747 22,701,709 48,600,000 -4,114,951 -3,708,613 -4,924,220 -1,675,854 -2,174,411 -1,762,465 -3,729,052 -1,459,472 -412,907 -1,664,697 165,318 -1,531,529 1,858,461 -1,186,584 -982,637 -1,024,033 -813,487 -1,360,387 -711,972 -525,083 -1,437,225 -63,026 -53,153 -269,555 126,202 -83,339 -187,444 -14,069 -3,384 -18,533 40,001 -74,663 12,613 60,807 -101,272 -112,778 -297,647 -336,805 -73,134 -59,368 
  net income22,059,000 13,170,000 13,132,000 -2,600,000 23,185,000 11,950,000 13,764,000 13,770,000 34,279,000 12,658,000 13,151,000 10,057,000 16,713,000 7,044,000 4,052,000 6,727,491 3,704,000 3,545,000 140,000 -3,095,952 9,106,397 2,664,102 2,160,455 37,900,000 -3,882,738 -3,611,812 -4,563,444 -1,732,706 -1,358,409 -1,315,257 -4,644,700 -1,685,611 -531,366 -2,482,366 190,413 -1,691,583 1,376,310 -1,677,741 -1,162,996 -1,162,996 -1,014,646 -1,532,117 -849,115 -822,981 -4,721,401 -3,202,826 -157,356 -426,787 58,204 -122,833 -228,930 -54,343 -41,015 -60,130 -843 -9,996 -28,925 55,849 -106,921 -139,122 -284,791 -353,055 -73,134 -59,368 

We provide you with 20 years income statements for Apollo Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Apollo Medical stock. Explore the full financial landscape of Apollo Medical stock with our expertly curated income statements.

The information provided in this report about Apollo Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.